Board Considerations for Covid‐19 Vaccine Programs
نویسندگان
چکیده
Erica L. Opitz and Diana Perez Gomez are attorneys with Chamberlain Hrdlicka, a law firm headquartered in Houston, providing expertise on variety of matters relating to corporate governance; commercial contract, mergers acquisitions: privately held securities, among others. In this article, they discuss the key factors that board should weigh when deciding whether require their employees receive COVID-19 vaccine.
منابع مشابه
On-board diagnostics for heavy-duty vehicles: Considerations for Mexico
On-board diagnostic (OBD) systems monitor the performance of engine and aftertreatment components including those responsible for controlling emissions.1 Historically, OBD systems were first deployed in light duty vehicles (LDVs), in 1991 the United States and 10 years later in Europe. Those first OBD systems were very basic and had very little standardization, meaning that each manufacturer ad...
متن کاملConsiderations for Developing a Zika Virus Vaccine.
Current prevention strategies fo cus on mosquito control, protec tion of the blood supply, barrier protection during sex, and other forms of contraception. When this explosive epidemic abates, Zika vi rus could remain endemic in many countries, where the risk to preg nant women, the general public, and travelers will persist. There fore, a safe and effective vaccine is essential. Developme...
متن کاملDengue Vaccine: Considerations before Rollout in Colombia
1 UMI233, Institut de Recherche pour le Développement (IRD), Université de Montpellier, Montpellier, France, 2 Laboratoire d'Informatique, de Robotique et de Microélectronique de Montpellier (LIRMM), Institut de Biologie Computationnelle (IBC), Université de Montpellier, Montpellier, France, 3 Laboratorio de Arbovirus, Centro de Investigaciones en Enfermedades Tropicales (CINTROP), Universidad ...
متن کاملAdaptive Immunity to Francisella tularensis and Considerations for Vaccine Development
Francisella tularensis is an intracellular bacterium that causes the disease tularemia. There are several subspecies of F. tularensis whose ability to cause disease varies in humans. The most virulent subspecies, tularensis, is a Tier One Select Agent and a potential bioweapon. Although considerable effort has made to generate efficacious tularemia vaccines, to date none have been licensed for ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Board Leadership
سال: 2021
ISSN: ['1061-4249', '1542-7862']
DOI: https://doi.org/10.1002/bl.30189